Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta

International Journal of Gynecological Cancer

Volumn 16, Issue 4, 2006, Pages 1679-1684

  Petignat, P ^a,b,f   Laurini, R ^c   Goffin, F ^d   Bruchim, I ^e   Bischof, P ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e MCGILL UNIVERSITY   (Canada)

^f NOTRE DAME HOSPITAL   (Canada)

Author keywords

Hydatidiform mole; MMP; p53; TIMP; Trophoblastic disease

Indexed keywords

CYTOKERATIN 7; GELATINASE A; GELATINASE B; MONOCLONAL ANTIBODY; PARAFFIN; PROTEIN P53; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PLACENTA; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SYNCYTIOTROPHOBLAST; TISSUE SECTION; TROPHOBLAST; WILD TYPE;

ADOLESCENT; ADULT; DNA; FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 2; MUTATION; PLACENTA; PLOIDIES; PREGNANCY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TROPHOBLASTS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS;

EID: 33745966500     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00643.x     Document Type: Article

References (34)

1. Bischof P, Meisser A, Campana A. Paracrine and autocrine regulators of trophoblast invasion-a review. Placenta 2000;21(Suppl. A):S55-S60.
2. Bischof P, Martelli M, Campana A, Itoh Y, Ogata Y, Nagase H. Importance of matrix metalloproteinases in human trophoblast invasion. Early Pregnancy 1995;1:263-9.
3. Librach CL, Werb Z, Fitzgerald ML et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991;113:437-49.
4. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980;1:3-19.
5. Bischof P, Meisser A, Campana A. Mechanisms of endometrial control of trophoblast invasion. J Reprod Fertil Suppl 2000;55:65-71.
6. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Inter-action of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992;267:4583-91.
7. Vassilakos P, Riotton G, Kajii T. Hydatidiform mole: two entities. A morphologic and cytogenetic study with some clinical consideration. Am J Obstet Gynecol 1977;127:167-70.
8. Szulman AE, Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 1978;132:20-7.
9. Szulman AE, Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978;131:665-71.
10. Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med 1996;335:1740-8.
11. Osathanondh R, Goldstein DP, Pastorfide GB. Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer 1975;36:863-6.
12. Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994;39:155-62.
13. Seckl MJ, Fisher RA, Salerno G et al. Choriocarcinoma and partial hydatidiform moles. Lancet 2000;356:36-9.
14. Meyer E, Vollmer JY, Bovey R, Stamenkovic I. Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis. Cancer Res 2005;65:4261-72.
15. Hedley DVV, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
16. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-21.
17. Bischof P, Irminger-Finger I. The human cytotrophoblastic cell, a mononuclear chameleon. Int J Biochem Cell Biol 2005;37:1-16.
18. Sequoia Ecosystem and Recreation Preserve Act of 1999. In 106th Congress ed.; 1999.
19. Vegh GL, Selcuk Tuncer Z, Fulop V, Genest DR, Mok SC, Berkowitz RS. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol 1999;75:248-53.
20. Okamoto T, Niu R, Yamada S, Osawa M. Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases. Mol Hum Reprod 2002;8:392-8.
21. Cadwell C, Zambetti GP. The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 2001;277:15-30.
22. Al-Bozom IA. p53 and Bcl-2 oncoprotein expression in placentas with hydropic changes and partial and complete moles. APMIS 2000;108:756-60.
23. Chen CA, Chen YH, Chen TM et al. Infrequent mutation in tumor suppressor gene p53 in gestational trophoblastic neoplasia. Carcinogenesis 1994;15:2221-3.
24. Cheung AN, Shen DH, Khoo US et al. Immunohistochemical and mutational analysis of p53 tumor suppressor gene in gestational trophoblastic disease: correlation with mdm2, proliferation index, and clinicopathologic parameters. Int J Gynecol Cancer 1999;9:123-30.
25. Cheung AN, Srivastava G, Chung LP et al. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas. J Reprod Med 1994;39:223-7.
26. Fulop V, Mok SC, Genest DR, Gati I, Doszpod J., Berkowitz RS. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 1998;43:119-27.
27. Halperin R, Peller S, Sandbank J, Bukovsky I, Schneider D. Expression of the p53 gene and apoptosis in gestational trophoblastic disease. Placenta 2000;21:58-62.
28. Uzunlar AK, Yilmaz F, Bayhan G, Akkus Z. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases. Eur J Gynaecol Oncol 2002;23:79-83.
29. Wu Y, Zhang Q, Tang H. [Detection of p53 gene mutations in human gestational trophoblastic neoplasia by polymerase chain reaction-single strand conformational polymorphism techniques] [Chinese]. Hunan Yi Ke Da Xue Xue Bao 1997;22:338-40.
30. Persaud V, Ganjei P, Nadji M. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease. West Indian Med J 1993;42:142-3.
31. Shi YF, Xie X, Zhao CL et al. Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours. Br J Cancer 1996;73:1216-9.
32. Rogel A, Popliker M, Webb CG., Oren M. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 1985;5:2851-5.
33. Lane DP, Benchimol S. p53: oncogene or anti-oncogene?. Genes Dev 1990;4:1-8.
34. Webley KM, Shorthouse AJ, Royds JA. Effect of mutation and conformation on the function of p53 in colorectal cancer. J Pathol 2000;191:361-7.